TC-I 2014
CAS No. 1221349-53-6
TC-I 2014( —— )
Catalog No. M33511 CAS No. 1221349-53-6
TC-I 2014 shows antiallodynic properties in pain models.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 128 | In Stock |
|
| 5MG | 123 | In Stock |
|
| 10MG | 202 | In Stock |
|
| 25MG | 407 | In Stock |
|
| 50MG | 641 | In Stock |
|
| 100MG | 1051 | In Stock |
|
| 200MG | 1423 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTC-I 2014
-
NoteResearch use only, not for human use.
-
Brief DescriptionTC-I 2014 shows antiallodynic properties in pain models.
-
DescriptionTC-I 2014 (compound 5) is a potent and orally active Benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonist, with IC50 values of 0.8 nM, 3.0 nM and 4.4 nM for canine, human and rat channels respectively. TC-I 2014 exhibits antiallodynic properties in pain models.
-
In VitroTC-I 2014 (compound 5) potently inhibits cold-induced TRPM8 currents in HEK293 cells stably expressing canine or human TRPM8, with IC50 values of 0.413 and 1 nM, respectively.
-
In VivoTC-I 2014 (10 mg/kg, Orally once) completely prevents icilin-induced WDS.Animal Model:TC-I 2014 (10 mg/kg, Orally once) completely prevents icilin-induced WDS.Dosage:3, 5.6, 10 mg/kg.Administration:Orally once.Result:Produced greater than 90% inhibition at 3, 5.6, and 10 mg/kg administered 2 h prior to icilin challenge.
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorTRP/TRPV Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1221349-53-6
-
Formula Weight467.41
-
Molecular FormulaC23H19F6N3O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (534.86 mM; Ultrasonic )
-
SMILESFC(F)(F)c1ccccc1-c1cc(c2[nH]c(nc2c1)C1=NOC2(C1)CCCCC2)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Parks DJ, et Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonists. J Med Chem. 2011 Jan 13;54(1):233-47.?
molnova catalog
related products
-
Methyl Kakuol
Methyl Kakuol is an agonist of TRPA1 with an EC50 of 0.27 μM and can be used in studies about acting as an active ingredient in MBST constituent Asiasari Radix.
-
GsMTx4
GsMTx-4, mechanosensitive and stretch-activated ion channel inhibitor.
-
M8-B Hydrochloride
M8-B Hydrochloride is a selective transient receptor potential melastatin-8 (TRPM8) channel antagonist.M8 B, a TRPM8 antagonist.
Cart
sales@molnova.com